The association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcomes in anthracycline-treated patients with cancer
Abdel-Qadir H, Carrasco R, Austin PC, Chen Y, Zhou L, Fang J, Su HMH, Lega IC, Kaul P, Neilan TG, Thavendiranathan P. JACC CardioOncol. 2023; 5(3):318-28. Epub 2023 May 2.